Determination of the factors that cause valproic acid resistance in the pediatric juvenile myoclonic epilepsy cohort
Juvenile myoclonic epilepsy (JME) has an approximate prevalence of 18%–20% among idiopathic generalized epilepsy types. Valproic acid (VPA) is the first line treatment of JME; however, resistance to VPA was detected as the most important prognostic entity for refractory seizures. The present study a...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Society of Turaz Bilim
2022-03-01
|
| Series: | Medicine Science |
| Subjects: | |
| Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=105012 |